Results of an open label study of zerit, videx, crixivan and norvir in protease inhibitor naive HIV-infected patients

被引：0
|
作者：
Anderson, R [1 ]
Williamson, D [1 ]
Corey, N [1 ]
Shultz, E [1 ]
Lenzi, D [1 ]
机构：
[1] Anderson Clin Res, Pittsburgh, PA USA
来源：
AIDS | 2000年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P78
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [41] Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks
    Murphy, RL
    ANTIVIRAL THERAPY, 1999, 4 : 85 - 87
  • [42] Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children
    Bitnun, A
    Sochett, E
    Babyn, P
    Holowka, S
    Stephens, D
    Read, S
    King, SM
    AIDS, 2003, 17 (09) : 1319 - 1327
  • [43] Successful treatment with atazanavir and lopinavir/ritonavir combination therapy in protease inhibitor-susceptible and protease inhibitor-resistant HIV-infected patients
    Gilliam, Bruce L.
    Chan-Tack, Kirk M.
    Qaqish, Roula B.
    Rode, Richard A.
    Fantry, Lori E.
    Redfield, Robert R.
    AIDS PATIENT CARE AND STDS, 2006, 20 (11) : 745 - 759
  • [44] Long-term follow-up of 11 protease inhibitor (PI)-naive and PI-treated HIV-infected patients harbouring virus with insertions in the HIV-1 protease gene
    Amiel, C.
    Charpentier, C.
    Desire, N.
    Bonnard, P.
    Lebrette, M-G
    Weiss, L.
    Pialoux, G.
    Schneider, V.
    HIV MEDICINE, 2011, 12 (03) : 138 - 144
  • [45] The efficacy of calcium carbonate in the treatment of protease inhibitor-induced persistent diarrhea in HIV-infected patients
    Turner, MJ
    Angel, JB
    Woodend, AK
    Giguère, P
    HIV CLINICAL TRIALS, 2004, 5 (01): : 19 - 24
  • [46] Open-label study of a twice-daily indiniavir 800-mg/ritonavir 200-mg regimen in HIV-infected adults failing a protease inhibitor regimen
    Katner, HP
    Paar, DP
    Nadler, JP
    Jensen, EH
    Wilson, HM
    Finn, TS
    Petruschke, RA
    Zeldin, RK
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (05) : 483 - 487
  • [47] Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy
    Casado, JL
    Arrizabalaga, J
    Montes, M
    Martí-Belda, P
    Tural, C
    Pinilla, J
    Gutierrez, C
    Portu, J
    Schuurman, R
    Aguirrebengoa, K
    AIDS, 1999, 13 (12) : 1497 - 1502
  • [48] Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients
    Beatty, G
    Chu, J
    Kulkarni, K
    Lipshutz, G
    Khalili, M
    Abbasi, F
    Stansell, J
    Reaven, GM
    HIV CLINICAL TRIALS, 2004, 5 (06): : 383 - 391
  • [49] Increase of atherogenic plasma profile in HIV-infected patients treated with protease inhibitor-containing regimens
    Bonnet, F
    Savès, M
    Droz, C
    Peuchant, E
    Chêne, G
    Beylot, J
    Morlat, P
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (02) : 199 - 200
  • [50] Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus
    Walli, R
    Michl, GM
    Mühlbayer, D
    Brinkmann, L
    Goebel, FD
    RESEARCH IN EXPERIMENTAL MEDICINE, 2000, 199 (05) : 253 - 262
12345